JP2024526293A5 - - Google Patents

Info

Publication number
JP2024526293A5
JP2024526293A5 JP2024500094A JP2024500094A JP2024526293A5 JP 2024526293 A5 JP2024526293 A5 JP 2024526293A5 JP 2024500094 A JP2024500094 A JP 2024500094A JP 2024500094 A JP2024500094 A JP 2024500094A JP 2024526293 A5 JP2024526293 A5 JP 2024526293A5
Authority
JP
Japan
Prior art keywords
exactly
polypeptide
amino acid
vector
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024526293A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/068509 external-priority patent/WO2023280807A1/en
Publication of JP2024526293A publication Critical patent/JP2024526293A/ja
Publication of JP2024526293A5 publication Critical patent/JP2024526293A5/ja
Pending legal-status Critical Current

Links

JP2024500094A 2021-07-05 2022-07-05 淋菌を標的とするワクチン Pending JP2024526293A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21183614 2021-07-05
EP21183614.3 2021-07-05
PCT/EP2022/068509 WO2023280807A1 (en) 2021-07-05 2022-07-05 Vaccines targeting neisseria gonorrhoeae

Publications (2)

Publication Number Publication Date
JP2024526293A JP2024526293A (ja) 2024-07-17
JP2024526293A5 true JP2024526293A5 (https=) 2025-07-14

Family

ID=77050766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500094A Pending JP2024526293A (ja) 2021-07-05 2022-07-05 淋菌を標的とするワクチン

Country Status (7)

Country Link
US (1) US20240424079A1 (https=)
EP (1) EP4366762A1 (https=)
JP (1) JP2024526293A (https=)
CN (1) CN117915944A (https=)
AU (1) AU2022307747A1 (https=)
CA (1) CA3224564A1 (https=)
WO (1) WO2023280807A1 (https=)

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8200523A (nl) 1982-02-11 1983-09-01 Univ Leiden Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
US4879236A (en) 1984-05-16 1989-11-07 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
AU622104B2 (en) 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
US4952500A (en) 1988-02-01 1990-08-28 University Of Georgia Research Foundation, Inc. Cloning systems for Rhodococcus and related bacteria
US5858652A (en) 1988-08-30 1999-01-12 Abbott Laboratories Detection and amplification of target nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US5302523A (en) 1989-06-21 1994-04-12 Zeneca Limited Transformation of plant cells
US5550318A (en) 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5322783A (en) 1989-10-17 1994-06-21 Pioneer Hi-Bred International, Inc. Soybean transformation by microparticle bombardment
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
WO1993004169A1 (en) 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US5610042A (en) 1991-10-07 1997-03-11 Ciba-Geigy Corporation Methods for stable transformation of wheat
ATE398679T1 (de) 1992-07-07 2008-07-15 Japan Tobacco Inc Verfahren zur transformation einer monokotyledon pflanze
US5702932A (en) 1992-07-20 1997-12-30 University Of Florida Microinjection methods to transform arthropods with exogenous DNA
JP2952041B2 (ja) 1992-07-27 1999-09-20 パイオニア ハイ−ブレッド インターナショナル,インコーポレイテッド 培養ダイズ細胞のagrobacterium媒介形質転換の改良法
DE4228457A1 (de) 1992-08-27 1994-04-28 Beiersdorf Ag Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
GB9222888D0 (en) 1992-10-30 1992-12-16 British Tech Group Tomography
FR2708288B1 (fr) 1993-07-26 1995-09-01 Bio Merieux Procédé d'amplification d'acides nucléiques par transcription utilisant le déplacement, réactifs et nécessaire pour la mise en Óoeuvre de ce procédé.
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
ATE220424T1 (de) 1994-05-28 2002-07-15 Tepnel Medical Ltd Herstellung von nukleinsaeurekopien
US5656610A (en) 1994-06-21 1997-08-12 University Of Southern California Producing a protein in a mammal by injection of a DNA-sequence into the tongue
US5942391A (en) 1994-06-22 1999-08-24 Mount Sinai School Of Medicine Nucleic acid amplification method: ramification-extension amplification method (RAM)
FR2722208B1 (fr) 1994-07-05 1996-10-04 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
US5871986A (en) 1994-09-23 1999-02-16 The General Hospital Corporation Use of a baculovirus to express and exogenous gene in a mammalian cell
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5935825A (en) 1994-11-18 1999-08-10 Shimadzu Corporation Process and reagent for amplifying nucleic acid sequences
US5780448A (en) 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
US5612473A (en) 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
EP0880360B1 (en) * 1996-02-12 2002-10-09 Cobra Therapeutics Limited Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
US5939291A (en) 1996-06-14 1999-08-17 Sarnoff Corporation Microfluidic method for nucleic acid amplification
US5945100A (en) 1996-07-31 1999-08-31 Fbp Corporation Tumor delivery vehicles
US5849546A (en) 1996-09-13 1998-12-15 Epicentre Technologies Corporation Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
US5981274A (en) 1996-09-18 1999-11-09 Tyrrell; D. Lorne J. Recombinant hepatitis virus vectors
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US5849497A (en) 1997-04-03 1998-12-15 The Research Foundation Of State University Of New York Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker
US5866366A (en) 1997-07-01 1999-02-02 Smithkline Beecham Corporation gidB
US5916776A (en) 1997-08-27 1999-06-29 Sarnoff Corporation Amplification method for a polynucleotide
US5994624A (en) 1997-10-20 1999-11-30 Cotton Incorporated In planta method for the production of transgenic plants
US5932451A (en) 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
NZ515935A (en) * 1999-05-19 2004-01-30 Chiron S Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US7683238B2 (en) 2002-11-12 2010-03-23 iBio, Inc. and Fraunhofer USA, Inc. Production of pharmaceutically active proteins in sprouted seedlings
ES2531125T3 (es) 2003-02-03 2015-03-10 Ibio Inc Sistema para la expresión de genes en plantas
EP1769068B1 (en) 2004-02-20 2014-12-31 iBio, Inc. Systems and methods for clonal expression in plants
EP2152301A4 (en) * 2007-04-28 2010-07-28 Fraunhofer Usa Inc TRYPANOSOMAANTIGEN, VACCINE COMPOSITIONS AND RELATED METHODS
FR2957821B1 (fr) 2010-03-24 2014-08-29 Inst Francais Du Petrole Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives
WO2020206072A1 (en) * 2019-04-03 2020-10-08 University Of Georgia Research Foundation, Inc. Delivery of crispr/mcas9 through extracellular vesicles for genome editing
US12599655B2 (en) * 2019-08-01 2026-04-14 Trustees Of Tufts College Neisseria gonorrhoeae vaccine compositions and methods of selecting antigens
JP7849292B2 (ja) * 2019-11-12 2026-04-21 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 潜伏形態のトキソプラズマ症についての新たな血清マーカー
MX2022006299A (es) * 2019-11-25 2023-01-19 Univ Griffith Proteína inmunogénica contra una infección gonocócica.
US20230050225A1 (en) * 2020-01-06 2023-02-16 Evaxion Biotech A/S Vaccines targeting Neisseria gonorrhoeae

Similar Documents

Publication Publication Date Title
US5786189A (en) Vaccine
US9346860B2 (en) Expression system
JP3267333B2 (ja) 融合タンパク質
EP0832093B1 (en) Expression of lipoproteins
CN102037135A (zh) 增强对有鞭毛的细菌的免疫反应的组合物和方法
US10780154B2 (en) Salmonella paratyphi A with an O-antigen having an extended carbohydrate chain and use thereof
AU2021269320A1 (en) Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a
US7355027B2 (en) Bacillus anthracis protective antigen
AU747328B2 (en) Secretion of carrier-bonded proteins into the periplasma and the extracellular space
JP2024526293A5 (https=)
CN106554421B (zh) 一种抑制链球菌和/或预防链球菌感染的融合蛋白疫苗
EP0202260B1 (en) Improved antigenic preparation
AU644828B2 (en) Novel vaccine
US8440427B2 (en) Preparation of protective antigen
CN107281487B (zh) 一种兽用疫苗佐剂
EP0555894B1 (en) Whooping cough vaccine
WO2014066341A1 (en) Use of the salmonella spp type iii secretion proteins as a protective vaccination
JP3693900B2 (ja) 1a5b構造を有する蛋白質の製造法
RU2794625C2 (ru) Пневмококковая вакцина, сочетающая выбранные альфа-спиральные домены и богатые пролином домены пневмококкового поверхностного белка а
CN102286106A (zh) 夹心外膜蛋白展示载体及应用其制备的大肠埃希菌疫苗
CA2081950A1 (en) Vaccine for the prevention of infections caused by pasteurella haemolytica
CA3044112C (en) Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein a
JP2002034568A (ja) 組換え豚丹毒菌防御抗原の回収精製法
CN116769056A (zh) 融合蛋白及纯化制备方法和应用
EP1801217A1 (en) Group A streptococcal vaccines